{"id":65,"date":"2021-08-01T03:57:26","date_gmt":"2021-08-01T03:57:26","guid":{"rendered":"https:\/\/www.fglawgroup.com\/?page_id=65"},"modified":"2021-08-01T03:57:26","modified_gmt":"2021-08-01T03:57:26","slug":"drug-and-medical-device-litigation","status":"publish","type":"page","link":"https:\/\/www.fglawgroup.com\/practices\/drug-and-medical-device-litigation\/","title":{"rendered":"Drug and Medical Device Litigation"},"content":{"rendered":"

The Food and Drug Administration has been a terribly ineffective regulatory agency for many years.\u00a0 Literally tens of thousands of people have been harmed by drugs that were approved by the FDA and then made it to market despite serious questions.\u00a0 (For details on FDA recalls, please see the information provided on our\u00a0Online Information\u00a0and\u00a0FAQ\u00a0pages.)<\/p>\n

Often these drugs are wholly ineffective while, at the same time, posing deadly risks to patients.\u00a0 On March 4, 2009, the United States Supreme Court ruled that FDA approval of a drug would not immunize drug manufacturers from liability for failing to warn consumers of the risks posed by such drugs.\u00a0 This landmark case out of Oregon,\u00a0Wyeth v. Levine, represents a substantial victory for consumers.<\/p>\n

Fischer, Goldasich & Aughtman, \u00a0LLC has substantial experience in prosecuting claims for injury caused by certain prescription drugs.\u00a0 As the United States Supreme Court has now recognized, claims presented by injured victims in court against drug manufacturers serve a critical role in holding manufacturers accountable and protecting consumers from unreasonable risks.<\/p>\n

Fischer, Goldasich & Aughtman, LLC is currently evaluating claims for injury caused by the following drugs and medical devices:<\/p>\n